blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3716970

EP3716970 - CORROLES FOR TREATING HUMAN CYTOMEGALOVIRUS INFECTIONS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  08.07.2022
Database last updated on 07.10.2024
FormerThe patent has been granted
Status updated on  30.07.2021
FormerGrant of patent is intended
Status updated on  07.04.2021
FormerRequest for examination was made
Status updated on  04.09.2020
FormerThe international publication has been made
Status updated on  07.06.2019
Formerunknown
Status updated on  21.12.2018
Most recent event   Tooltip13.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 16.10.2024 [2024/42]
Applicant(s)For all designated states
Université de Bourgogne
Esplanade Erasme - BP 27877
21078 Dijon Cedex / FR
[2020/41]
Inventor(s)01 / GROS, Claude
3 rue Jean Moulin
21800 Neuilly Les Dijon / FR
02 / GALLARDO, Franck
858 avenue de Montech
82000 Montauban / FR
03 / DESBOIS, Nicolas
1 Impasse du Tilleul
21110 Bessey Les Citeaux / FR
 [2020/41]
Representative(s)IPAZ
Bâtiment Platon
Parc Les Algorithmes
91190 Saint-Aubin / FR
[N/P]
Former [2020/41]IPAZ
Parc Les Algorithmes, Bâtiment Platon
CS 70003 Saint-Aubin
91192 Gif-sur-Yvette Cedex / FR
Application number, filing date18815547.727.11.2018
[2020/41]
WO2018EP82695
Priority number, dateEP2017030665529.11.2017         Original published format: EP 17306655
[2020/41]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019105928
Date:06.06.2019
Language:EN
[2019/23]
Type: A1 Application with search report 
No.:EP3716970
Date:07.10.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 06.06.2019 takes the place of the publication of the European patent application.
[2020/41]
Type: B1 Patent specification 
No.:EP3716970
Date:01.09.2021
Language:EN
[2021/35]
Search report(s)International search report - published on:EP06.06.2019
ClassificationIPC:A61K31/409, A61P31/22, A61P31/12, A61K45/06, A61K31/517, A61K31/522, A61K31/675, A61K31/662
[2021/16]
CPC:
A61K31/409 (EP,US); A61K31/444 (US); A61K31/496 (US);
A61K31/517 (EP); A61K31/522 (EP,US); A61K31/662 (EP,US);
A61K31/675 (EP,US); A61K45/06 (EP); A61P31/12 (EP);
A61P31/22 (EP,US) (-)
C-Set:
A61K31/409, A61K2300/00 (EP);
A61K31/517, A61K2300/00 (EP);
A61K31/522, A61K2300/00 (EP);
A61K31/662, A61K2300/00 (EP);
A61K31/675, A61K2300/00 (EP)
(-)
Former IPC [2020/41]A61K31/409, A61K45/06, A61P31/12, A61P31/22
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/41]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:KORROLEN ZUR BEHANDLUNG VON HUMANEN CYTOMEGALOVIRUS-INFEKTIONEN[2020/41]
English:CORROLES FOR TREATING HUMAN CYTOMEGALOVIRUS INFECTIONS[2020/41]
French:CORROLES PERMETTANT DE TRAITER DES INFECTIONS À CYTOMÉGALOVIRUS HUMAIN[2021/16]
Former [2020/41]CORROLES POUR LE TRAITEMENT D'INFECTIONS PAR LE CYTOMÉGALOVIRUS HUMAIN
Entry into regional phase16.06.2020National basic fee paid 
16.06.2020Designation fee(s) paid 
16.06.2020Examination fee paid 
Examination procedure16.06.2020Examination requested  [2020/41]
16.06.2020Date on which the examining division has become responsible
22.12.2020Amendment by applicant (claims and/or description)
08.04.2021Communication of intention to grant the patent
27.07.2021Fee for grant paid
27.07.2021Fee for publishing/printing paid
27.07.2021Receipt of the translation of the claim(s)
Opposition(s)02.06.2022No opposition filed within time limit [2022/32]
Fees paidRenewal fee
27.11.2020Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU27.11.2018
AL01.09.2021
AT01.09.2021
CY01.09.2021
CZ01.09.2021
DK01.09.2021
EE01.09.2021
ES01.09.2021
FI01.09.2021
HR01.09.2021
IT01.09.2021
LT01.09.2021
LV01.09.2021
MC01.09.2021
MK01.09.2021
MT01.09.2021
NL01.09.2021
PL01.09.2021
RO01.09.2021
RS01.09.2021
SE01.09.2021
SI01.09.2021
SK01.09.2021
SM01.09.2021
TR01.09.2021
IE27.11.2021
LU27.11.2021
BE30.11.2021
BG01.12.2021
NO01.12.2021
GR02.12.2021
IS01.01.2022
PT03.01.2022
[2024/42]
Former [2024/29]HU27.11.2018
AL01.09.2021
AT01.09.2021
CY01.09.2021
CZ01.09.2021
DK01.09.2021
EE01.09.2021
ES01.09.2021
FI01.09.2021
HR01.09.2021
IT01.09.2021
LT01.09.2021
LV01.09.2021
MC01.09.2021
MK01.09.2021
NL01.09.2021
PL01.09.2021
RO01.09.2021
RS01.09.2021
SE01.09.2021
SI01.09.2021
SK01.09.2021
SM01.09.2021
TR01.09.2021
IE27.11.2021
LU27.11.2021
BE30.11.2021
BG01.12.2021
NO01.12.2021
GR02.12.2021
IS01.01.2022
PT03.01.2022
Former [2024/23]HU27.11.2018
AL01.09.2021
AT01.09.2021
CY01.09.2021
CZ01.09.2021
DK01.09.2021
EE01.09.2021
ES01.09.2021
FI01.09.2021
HR01.09.2021
IT01.09.2021
LT01.09.2021
LV01.09.2021
MC01.09.2021
MK01.09.2021
NL01.09.2021
PL01.09.2021
RO01.09.2021
RS01.09.2021
SE01.09.2021
SI01.09.2021
SK01.09.2021
SM01.09.2021
IE27.11.2021
LU27.11.2021
BE30.11.2021
BG01.12.2021
NO01.12.2021
GR02.12.2021
IS01.01.2022
PT03.01.2022
Former [2023/33]HU27.11.2018
AL01.09.2021
AT01.09.2021
CY01.09.2021
CZ01.09.2021
DK01.09.2021
EE01.09.2021
ES01.09.2021
FI01.09.2021
HR01.09.2021
IT01.09.2021
LT01.09.2021
LV01.09.2021
MC01.09.2021
NL01.09.2021
PL01.09.2021
RO01.09.2021
RS01.09.2021
SE01.09.2021
SI01.09.2021
SK01.09.2021
SM01.09.2021
IE27.11.2021
LU27.11.2021
BE30.11.2021
BG01.12.2021
NO01.12.2021
GR02.12.2021
IS01.01.2022
PT03.01.2022
Former [2023/30]AL01.09.2021
AT01.09.2021
CY01.09.2021
CZ01.09.2021
DK01.09.2021
EE01.09.2021
ES01.09.2021
FI01.09.2021
HR01.09.2021
IT01.09.2021
LT01.09.2021
LV01.09.2021
MC01.09.2021
NL01.09.2021
PL01.09.2021
RO01.09.2021
RS01.09.2021
SE01.09.2021
SI01.09.2021
SK01.09.2021
SM01.09.2021
IE27.11.2021
LU27.11.2021
BE30.11.2021
BG01.12.2021
NO01.12.2021
GR02.12.2021
IS01.01.2022
PT03.01.2022
Former [2022/48]AL01.09.2021
AT01.09.2021
CZ01.09.2021
DK01.09.2021
EE01.09.2021
ES01.09.2021
FI01.09.2021
HR01.09.2021
IT01.09.2021
LT01.09.2021
LV01.09.2021
MC01.09.2021
NL01.09.2021
PL01.09.2021
RO01.09.2021
RS01.09.2021
SE01.09.2021
SI01.09.2021
SK01.09.2021
SM01.09.2021
IE27.11.2021
LU27.11.2021
BE30.11.2021
BG01.12.2021
NO01.12.2021
GR02.12.2021
IS01.01.2022
PT03.01.2022
Former [2022/36]AL01.09.2021
AT01.09.2021
CZ01.09.2021
DK01.09.2021
EE01.09.2021
ES01.09.2021
FI01.09.2021
HR01.09.2021
IT01.09.2021
LT01.09.2021
LV01.09.2021
MC01.09.2021
NL01.09.2021
PL01.09.2021
RO01.09.2021
RS01.09.2021
SE01.09.2021
SI01.09.2021
SK01.09.2021
SM01.09.2021
LU27.11.2021
BE30.11.2021
BG01.12.2021
NO01.12.2021
GR02.12.2021
IS01.01.2022
PT03.01.2022
Former [2022/34]AL01.09.2021
AT01.09.2021
CZ01.09.2021
EE01.09.2021
ES01.09.2021
FI01.09.2021
HR01.09.2021
LT01.09.2021
LV01.09.2021
MC01.09.2021
NL01.09.2021
PL01.09.2021
RO01.09.2021
RS01.09.2021
SE01.09.2021
SK01.09.2021
SM01.09.2021
LU27.11.2021
BE30.11.2021
BG01.12.2021
NO01.12.2021
GR02.12.2021
IS01.01.2022
PT03.01.2022
Former [2022/33]AL01.09.2021
AT01.09.2021
CZ01.09.2021
EE01.09.2021
ES01.09.2021
FI01.09.2021
HR01.09.2021
LT01.09.2021
LV01.09.2021
MC01.09.2021
NL01.09.2021
PL01.09.2021
RO01.09.2021
RS01.09.2021
SE01.09.2021
SK01.09.2021
SM01.09.2021
BE30.11.2021
BG01.12.2021
NO01.12.2021
GR02.12.2021
IS01.01.2022
PT03.01.2022
Former [2022/29]AL01.09.2021
AT01.09.2021
CZ01.09.2021
EE01.09.2021
ES01.09.2021
FI01.09.2021
HR01.09.2021
LT01.09.2021
LV01.09.2021
NL01.09.2021
PL01.09.2021
RO01.09.2021
RS01.09.2021
SE01.09.2021
SK01.09.2021
SM01.09.2021
BG01.12.2021
NO01.12.2021
GR02.12.2021
IS01.01.2022
PT03.01.2022
Former [2022/25]AT01.09.2021
CZ01.09.2021
EE01.09.2021
ES01.09.2021
FI01.09.2021
HR01.09.2021
LT01.09.2021
LV01.09.2021
NL01.09.2021
PL01.09.2021
RO01.09.2021
RS01.09.2021
SE01.09.2021
SK01.09.2021
SM01.09.2021
BG01.12.2021
NO01.12.2021
GR02.12.2021
IS01.01.2022
PT03.01.2022
Former [2022/24]AT01.09.2021
CZ01.09.2021
EE01.09.2021
ES01.09.2021
FI01.09.2021
HR01.09.2021
LT01.09.2021
LV01.09.2021
NL01.09.2021
PL01.09.2021
RO01.09.2021
RS01.09.2021
SE01.09.2021
SK01.09.2021
BG01.12.2021
NO01.12.2021
GR02.12.2021
IS01.01.2022
PT03.01.2022
Former [2022/21]AT01.09.2021
ES01.09.2021
FI01.09.2021
HR01.09.2021
LT01.09.2021
LV01.09.2021
PL01.09.2021
RS01.09.2021
SE01.09.2021
BG01.12.2021
NO01.12.2021
GR02.12.2021
Former [2022/10]ES01.09.2021
FI01.09.2021
HR01.09.2021
LT01.09.2021
LV01.09.2021
PL01.09.2021
RS01.09.2021
SE01.09.2021
BG01.12.2021
NO01.12.2021
GR02.12.2021
Former [2022/09]ES01.09.2021
FI01.09.2021
LT01.09.2021
RS01.09.2021
SE01.09.2021
BG01.12.2021
NO01.12.2021
Former [2022/08]ES01.09.2021
FI01.09.2021
LT01.09.2021
SE01.09.2021
BG01.12.2021
NO01.12.2021
Former [2022/07]LT01.09.2021
NO01.12.2021
Cited inInternational search[AD]  - GROS CLAUDE P ET AL, "Synthesis and Antiviral Activity Evaluation of Nitroporphyrins and Nitrocorroles as Potential Agents against Human Cytomegalovirus Infection.", ACS INFECTIOUS DISEASES 14 AUG 2015, (20150814), vol. 1, no. 8, ISSN 2373-8227, pages 350 - 356, XP009504313 [AD] 1-13 * the whole document *

DOI:   http://dx.doi.org/10.1021/acsinfecdis.5b00020
 [A]  - KARL M. KADISH ET AL, "Clarification of the Oxidation State of Cobalt Corroles in Heterogeneous and Homogeneous Catalytic Reduction of Dioxygen", INORGANIC CHEMISTRY, EASTON, US, (20080627), vol. 47, no. 15, doi:10.1021/ic800458s, ISSN 0020-1669, pages 6726 - 6737, XP055461939 [A] 1-13 * the whole document *

DOI:   http://dx.doi.org/10.1021/ic800458s
 [A]  - Carla M.B. Carvalho, "Antimicrobial photodynamic activity of porphyrin derivatives: potential application on medical and water disinfection", Journal of Porphyrins and Phthalocyanines, (20090101), pages 574 - 577, URL: https://www.worldscientific.com/doi/pdf/10.1142/S1088424609000528, (20180321), XP055461677 [A] 1-13 * abstract * * page 575; figure 2 *
 [AD]  - GRYKO D T ET AL, "Refined methods for the synthesis of meso-substituted A3- and trans-A2B-corroles", ORGANIC & BIOMOLECULAR CHEMISTRY,, vol. 1, no. 2, doi:10.1039/B208950E, ISSN 1477-0520, (20030101), pages 350 - 357, (20021209), XP002595975 [AD] 1-13 * the whole document *

DOI:   http://dx.doi.org/10.1039/B208950E
by applicant   - GROS et al., Acs Infect. Dis., (20150000), vol. 1, pages 350 - 356
    - PAOLESSE et al., J. Org. Chem., (20010000), vol. 66, no. 2, pages 550 - 556
    - GRYKO, D. T.; KOSZARNA, B., Org. Biomol. Chem., (20030000), vol. 1, no. 2, pages 350 - 357
    - STRAETEMANS R et al., Biometrical Journal, (20050000), vol. 47, no. 3, pages 299 - 308
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.